NO20003393L - FremgangsmÕte for fremstilling av en farmasøytisk formulering - Google Patents

FremgangsmÕte for fremstilling av en farmasøytisk formulering

Info

Publication number
NO20003393L
NO20003393L NO20003393A NO20003393A NO20003393L NO 20003393 L NO20003393 L NO 20003393L NO 20003393 A NO20003393 A NO 20003393A NO 20003393 A NO20003393 A NO 20003393A NO 20003393 L NO20003393 L NO 20003393L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
NO20003393A
Other languages
English (en)
Other versions
NO20003393D0 (no
Inventor
Tapio Lankinen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO20003393D0 publication Critical patent/NO20003393D0/no
Publication of NO20003393L publication Critical patent/NO20003393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
NO20003393A 1997-12-31 2000-06-29 FremgangsmÕte for fremstilling av en farmasøytisk formulering NO20003393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974664A FI105074B (fi) 1997-12-31 1997-12-31 Farmaseuttisen formulaation valmistusmenetelmä
PCT/FI1998/001001 WO1999034778A1 (en) 1997-12-31 1998-12-21 A method for making a pharmaceutical formulation

Publications (2)

Publication Number Publication Date
NO20003393D0 NO20003393D0 (no) 2000-06-29
NO20003393L true NO20003393L (no) 2000-07-31

Family

ID=8550254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003393A NO20003393L (no) 1997-12-31 2000-06-29 FremgangsmÕte for fremstilling av en farmasøytisk formulering

Country Status (17)

Country Link
US (1) US6616945B1 (no)
EP (1) EP1041971A1 (no)
JP (2) JP4131610B2 (no)
KR (1) KR20010033725A (no)
CN (1) CN1172659C (no)
AU (1) AU754074B2 (no)
CA (1) CA2314112C (no)
DE (1) DE1041971T1 (no)
EE (1) EE04993B1 (no)
FI (1) FI105074B (no)
HU (1) HUP0100398A2 (no)
IL (1) IL137017A0 (no)
NO (1) NO20003393L (no)
NZ (1) NZ505400A (no)
PL (1) PL341410A1 (no)
RU (1) RU2203045C2 (no)
WO (1) WO1999034778A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI116657B (fi) * 2002-03-28 2006-01-31 Focus Inhalation Oy Menetelmä kantoainehiukkasten käsittelemiseksi ja niiden käyttö
BR0308984A (pt) * 2002-04-04 2005-02-09 Boehringer Ingelheim Pharma Formulações em pó adequadas para inalação
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20090211576A1 (en) * 2007-10-02 2009-08-27 Timo Lehtonen Safety and abuse deterrent improved device
KR101936968B1 (ko) 2010-10-18 2019-01-09 다이닛본 스미토모 세이야꾸 가부시끼가이샤 주사용 서방형 제제
CN110025578B (zh) * 2019-04-10 2021-06-15 深圳市新阳唯康科技有限公司 一种治疗哮喘类肺部疾病的共无定形粉末及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
ES2087911T3 (es) 1989-04-28 1996-08-01 Riker Laboratories Inc Dispositivo de inhalacion de polvo seco.
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5393716A (en) * 1992-09-25 1995-02-28 Ecc International Limited Process for producing anti-blocking compositions
US5503869A (en) 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus

Also Published As

Publication number Publication date
KR20010033725A (ko) 2001-04-25
NZ505400A (en) 2003-06-30
IL137017A0 (en) 2001-06-14
WO1999034778A1 (en) 1999-07-15
CA2314112C (en) 2008-06-17
AU754074B2 (en) 2002-11-07
EP1041971A1 (en) 2000-10-11
HUP0100398A2 (hu) 2001-08-28
EE04993B1 (et) 2008-04-15
FI974664A0 (fi) 1997-12-31
EE200000401A (et) 2001-10-15
CA2314112A1 (en) 1999-07-15
PL341410A1 (en) 2001-04-09
RU2203045C2 (ru) 2003-04-27
FI974664A (fi) 1999-07-01
DE1041971T1 (de) 2001-02-08
CN1283109A (zh) 2001-02-07
FI105074B (fi) 2000-06-15
AU1760899A (en) 1999-07-26
CN1172659C (zh) 2004-10-27
JP2002500176A (ja) 2002-01-08
NO20003393D0 (no) 2000-06-29
JP2008019279A (ja) 2008-01-31
US6616945B1 (en) 2003-09-09
JP4131610B2 (ja) 2008-08-13

Similar Documents

Publication Publication Date Title
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
ID24654A (id) Formulasi farmasi omeprazola
NO973612L (no) Nytt farmasöytisk preparat
BR9611367A (pt) Formulação farmacêutic liofilizada estável
NO995533L (no) Ny fremgangsmåte for fremstilling av en farmakologisk aktiv substans
BR9610396A (pt) Formulação farmacêutica
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO973610D0 (no) Nytt farmasöytisk preparat
NO20023937L (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
FI973230A (fi) Uusi farmaseuttinen formulaatio
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
FI951155A0 (fi) Farmaseuttinen valmiste
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994793D0 (no) FremgangsmÕte for fremstilling av clavulansyre
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application